About

Steven Perrault, PhD, is a graduate of the Institute of Biomedical Engineering and the University of Toronto, where he pioneered methods in gold nanoparticle synthesis and modification, applying this to improve our understanding of how nanoparticle properties determine in vivo and tumour distribution behaviour for targeting applications. He also pioneered the field of in vivo assembly of nanomaterial components. He then spent four years as a Technology Development Fellow at the Wyss Institute for Biologically Inspired Engineering at Harvard, characterizing and solving challenges with stability of DNA nanostructures in vitro and in vivo through LNP encapsulation. Since then, he was part of the team that built ReadCoor, Inc, a start-up focused on developing one of the first spatial sequencing platforms, and and then worked at Foundation Medicine as an R&D lead in Assay Development, focused on development of personalized cancer vaccine technology and liquid biopsy comprehensive genomic assay development. Steve is passionate about science, bioengineering, and biomedical applications of novel technologies.

Link to Publications